HF
IRMD icon

HRT Financial’s iRadimed IRMD Stock Holding History

HRT Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.58M Buy
47,537
+20,967
+79% +$2.1M 0.01% 1054
2025
Q4 		$2.58M Buy
26,570
+6,783
+34% +$582K 0.01% 1136
2025
Q3 		$1.41M Buy
+19,787
New +$1.32M 0.01% 1347
2025
Q1 		– Sell
-5,039
Closed -$277K – 2931
2024
Q4 		$277K Sell
5,039
-3,500
-41% -$184K ﹤0.01% 1759
2024
Q3 		$429K Sell
8,539
-7,467
-47% -$344K ﹤0.01% 1656
2024
Q2 		$703K Buy
16,006
+10,494
+190% +$446K ﹤0.01% 1156
2024
Q1 		$242K Buy
+5,512
New +$244K ﹤0.01% 1666

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's IRMD Position: Q1 2026 in Review

HRT Financial increased its iRadimed (IRMD) stake by 79% in Q1 2026, buying an estimated $2.1M and bringing the position to 47,537 shares worth $4.58M. The position accounts for 0.01% of the portfolio, ranked #1054.

HRT Financial first reported a position in IRMD in Q1 2024 and has held it in 7 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • HRT Financial held 47,537 shares of iRadimed worth $4.58M as of Q1 2026.
  • HRT Financial bought 20,967 iRadimed shares in Q1 2026, an estimated $2.1M.
  • iRadimed made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1054 holding.
  • HRT Financial first reported a position in iRadimed in Q1 2024 and has held it in 7 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.